If that legislation — which passed the state Legislature unanimously — becomes law and all litigating subdivisions within New York sign on to today’s settlement, New York would be eligible to receive more than half of total payments, or more than $130 million, as soon as February 2022. Today’s agreement also makes enforceable a bar stopping J&J and all of its subsidiaries, predecessors, and successors from manufacturing or selling opioids anywhere in New York, and acknowledges Johnson & Johnson’s exit from the opioid business nationally.
“The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids,” James commented.
“Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business — not only in New York, but across the entire country. Opioids will no longer be manufactured or sold in the United States by J&J,” she stated.
James also addressed the issue on social media, writing, “This is a major step in our fight to end the opioid epidemic, but our work isn’t over.”
No amount of money will ever compensate for the countless lives lost or those who became addicted to opioids across our state, but these funds will be used to prevent future devastation.
“The administration seems to have few real solutions to the crisis after revoking the former administration’s border security policies, such as ending the ‘Remain in Mexico’ policy,” the outlet said.
Meanwhile, Vice President Kamala Harris failed to mention illegal immigration’s impact on Americans and communities across the nation during her first visit to the U.S.-Mexico border Friday, according to Breitbart News.